Evaluation of hepatic impairment on pharmacokinetics and safety of crizotinib in patients with advanced cancer.
Anthony B El-KhoueiryJohn SarantopoulosCindy L O'BryantKristen K CiomborHuiping XuMelissa O'GormanJayeta ChakrabartiTiziana UsariBassel F El-RayesPublished in: Cancer chemotherapy and pharmacology (2018)
NCT01576406.